Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers.
Bommart S, Cournil A, Eymard-Duvernay S, Raffi F, Bouassida I, Le Moing V, Reynes J, Makinson A; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) HIV CHEST Study Team. Bommart S, et al. Among authors: raffi f. HIV Med. 2017 Nov;18(10):787-789. doi: 10.1111/hiv.12517. Epub 2017 May 15. HIV Med. 2017. PMID: 28503852 Free article. No abstract available.
Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. APROCO Study Group.
Le Moing V, Chêne G, Masquelier B, Sicard D, Brun-Vézinet F, Reynes J, Raffi F. Le Moing V, et al. Among authors: raffi f. J Acquir Immune Defic Syndr. 2000 May 1;24(1):82-3. doi: 10.1097/00126334-200005010-00016. J Acquir Immune Defic Syndr. 2000. PMID: 10877502 No abstract available.
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.
Savès M, Raffi F, Clevenbergh P, Marchou B, Waldner-Combernoux A, Morlat P, Le Moing V, Rivière C, Chêne G, Leport C. Savès M, et al. Among authors: raffi f. Antimicrob Agents Chemother. 2000 Dec;44(12):3451-5. doi: 10.1128/AAC.44.12.3451-3455.2000. Antimicrob Agents Chemother. 2000. PMID: 11083658 Free PMC article.
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors.
Le Moing V, Chêne G, Carrieri MP, Besnier JM, Masquelier B, Salamon R, Bazin C, Moatti JP, Raffi F, Leport C; APROCO Study Group. Le Moing V, et al. Among authors: raffi f. J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):372-6. doi: 10.1097/00126334-200108010-00007. J Acquir Immune Defic Syndr. 2001. PMID: 11468425
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort].
Brunet-François C, Taieb A, Masquelier B, Le Moing V, Lewden C, Dellamonica P, Cuzin L, Allavena C, Spire B, Chêne G, Raffi F; Groupe d'Etude Aproco-Copilote (ANRS C08). Brunet-François C, et al. Among authors: raffi f. Med Mal Infect. 2007 Mar;37(3):172-7. doi: 10.1016/j.medmal.2006.11.003. Epub 2007 Jan 17. Med Mal Infect. 2007. PMID: 17239554 French.
716 results